
Bradley T. King
Examiner (ID: 11299, Phone: (571)272-7117 , Office: P/3657 )
| Most Active Art Unit | 3657 |
| Art Unit(s) | 3613, 3683, 3616, 3657 |
| Total Applications | 1550 |
| Issued Applications | 1006 |
| Pending Applications | 124 |
| Abandoned Applications | 443 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6016738
[patent_doc_number] => 20110224200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'THERAPEUTIC AGENT FOR CHORIORETINAL DEGENERATIVE DISEASE CONTAINING PYRIDINE-3-CARBALDEHYDE 0-(PIPERIDIN-1-YL-PROPYL)-OXIME DERIVATIVE AS ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 13/129569
[patent_app_country] => US
[patent_app_date] => 2009-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4699
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224200.pdf
[firstpage_image] =>[orig_patent_app_number] => 13129569
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129569 | THERAPEUTIC AGENT FOR CHORIORETINAL DEGENERATIVE DISEASE CONTAINING PYRIDINE-3-CARBALDEHYDE 0-(PIPERIDIN-1-YL-PROPYL)-OXIME DERIVATIVE AS ACTIVE INGREDIENT | Nov 17, 2009 | Abandoned |
Array
(
[id] => 7580911
[patent_doc_number] => 20110294794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'TREATMENT OF PROTEINOPATHIES USING A FARNESYL TRANSFERASE INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 13/129360
[patent_app_country] => US
[patent_app_date] => 2009-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 108506
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294794.pdf
[firstpage_image] =>[orig_patent_app_number] => 13129360
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129360 | TREATMENT OF PROTEINOPATHIES USING A FARNESYL TRANSFERASE INHIBITOR | Nov 12, 2009 | Abandoned |
Array
(
[id] => 6590008
[patent_doc_number] => 20100062081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Use of tellurium containing compounds as nerve protecting agents'
[patent_app_type] => utility
[patent_app_number] => 12/591175
[patent_app_country] => US
[patent_app_date] => 2009-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13639
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20100062081.pdf
[firstpage_image] =>[orig_patent_app_number] => 12591175
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/591175 | Use of tellurium containing compounds as nerve protecting agents | Nov 11, 2009 | Abandoned |
Array
(
[id] => 6090609
[patent_doc_number] => 20110218190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'THERAPEUTIC USES OF AMPA RECEPTOR MODULATORS FOR TREATMENT OF MOTOR DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 13/128326
[patent_app_country] => US
[patent_app_date] => 2009-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14384
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20110218190.pdf
[firstpage_image] =>[orig_patent_app_number] => 13128326
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/128326 | THERAPEUTIC USES OF AMPA RECEPTOR MODULATORS FOR TREATMENT OF MOTOR DYSFUNCTION | Nov 8, 2009 | Abandoned |
Array
(
[id] => 6219953
[patent_doc_number] => 20100055048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'ACUTE TREATMENT OF HEADACHE WITH PHENOTHIAZINE ANTIPSYCHOTICS'
[patent_app_type] => utility
[patent_app_number] => 12/615185
[patent_app_country] => US
[patent_app_date] => 2009-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22121
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055048.pdf
[firstpage_image] =>[orig_patent_app_number] => 12615185
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/615185 | ACUTE TREATMENT OF HEADACHE WITH PHENOTHIAZINE ANTIPSYCHOTICS | Nov 8, 2009 | Abandoned |
Array
(
[id] => 6596964
[patent_doc_number] => 20100048634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'METHOD FOR TREATING APATHY SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 12/611704
[patent_app_country] => US
[patent_app_date] => 2009-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5437
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048634.pdf
[firstpage_image] =>[orig_patent_app_number] => 12611704
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/611704 | METHOD FOR TREATING APATHY SYNDROME | Nov 2, 2009 | Abandoned |
Array
(
[id] => 6425290
[patent_doc_number] => 20100168119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'COMPOSITIONS AND METHODS FOR MINIMIZING OR REDUCING AGONIST-INDUCED DESENSITIZATION'
[patent_app_type] => utility
[patent_app_number] => 12/603235
[patent_app_country] => US
[patent_app_date] => 2009-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9712
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168119.pdf
[firstpage_image] =>[orig_patent_app_number] => 12603235
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/603235 | COMPOSITIONS AND METHODS FOR MINIMIZING OR REDUCING AGONIST-INDUCED DESENSITIZATION | Oct 20, 2009 | Abandoned |
Array
(
[id] => 6322119
[patent_doc_number] => 20100113604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY'
[patent_app_type] => utility
[patent_app_number] => 12/580726
[patent_app_country] => US
[patent_app_date] => 2009-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25248
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113604.pdf
[firstpage_image] =>[orig_patent_app_number] => 12580726
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/580726 | COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY | Oct 15, 2009 | Abandoned |
Array
(
[id] => 6321973
[patent_doc_number] => 20100113581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY'
[patent_app_type] => utility
[patent_app_number] => 12/580447
[patent_app_country] => US
[patent_app_date] => 2009-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25446
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113581.pdf
[firstpage_image] =>[orig_patent_app_number] => 12580447
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/580447 | COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY | Oct 15, 2009 | Abandoned |
Array
(
[id] => 8802395
[patent_doc_number] => 08440669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-14
[patent_title] => 'Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-IV, and other antidiabetic or antiobesity agents as active ingredients'
[patent_app_type] => utility
[patent_app_number] => 13/124150
[patent_app_country] => US
[patent_app_date] => 2009-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15797
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13124150
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/124150 | Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-IV, and other antidiabetic or antiobesity agents as active ingredients | Oct 15, 2009 | Issued |
Array
(
[id] => 6321965
[patent_doc_number] => 20100113580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY'
[patent_app_type] => utility
[patent_app_number] => 12/580380
[patent_app_country] => US
[patent_app_date] => 2009-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25869
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113580.pdf
[firstpage_image] =>[orig_patent_app_number] => 12580380
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/580380 | COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY | Oct 15, 2009 | Abandoned |
Array
(
[id] => 6321994
[patent_doc_number] => 20100113583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY'
[patent_app_type] => utility
[patent_app_number] => 12/579631
[patent_app_country] => US
[patent_app_date] => 2009-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26560
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113583.pdf
[firstpage_image] =>[orig_patent_app_number] => 12579631
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/579631 | COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY | Oct 14, 2009 | Abandoned |
Array
(
[id] => 6322115
[patent_doc_number] => 20100113603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY'
[patent_app_type] => utility
[patent_app_number] => 12/579632
[patent_app_country] => US
[patent_app_date] => 2009-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25907
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113603.pdf
[firstpage_image] =>[orig_patent_app_number] => 12579632
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/579632 | COMBINATION THERAPIES FOR THE TREATMENT OF OBESITY | Oct 14, 2009 | Abandoned |
Array
(
[id] => 6453419
[patent_doc_number] => 20100189653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'Pyrone analogs for therapeutic treatment'
[patent_app_type] => utility
[patent_app_number] => 12/587704
[patent_app_country] => US
[patent_app_date] => 2009-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 50196
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20100189653.pdf
[firstpage_image] =>[orig_patent_app_number] => 12587704
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/587704 | Pyrone analogs for therapeutic treatment | Oct 8, 2009 | Abandoned |
Array
(
[id] => 8028387
[patent_doc_number] => 08143269
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-27
[patent_title] => 'Inhibitors of store operated calcium release'
[patent_app_type] => utility
[patent_app_number] => 12/573639
[patent_app_country] => US
[patent_app_date] => 2009-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 67456
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/143/08143269.pdf
[firstpage_image] =>[orig_patent_app_number] => 12573639
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/573639 | Inhibitors of store operated calcium release | Oct 4, 2009 | Issued |
Array
(
[id] => 7756781
[patent_doc_number] => 20120028929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'TETRACYCLINE STABILIZING FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/119547
[patent_app_country] => US
[patent_app_date] => 2009-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10334
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028929.pdf
[firstpage_image] =>[orig_patent_app_number] => 13119547
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/119547 | TETRACYCLINE STABILIZING FORMULATIONS | Sep 17, 2009 | Abandoned |
Array
(
[id] => 6302302
[patent_doc_number] => 20100068200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Methods and Compositions for Inhibiting Atherosclerosis and Vascular Inflammation'
[patent_app_type] => utility
[patent_app_number] => 12/558797
[patent_app_country] => US
[patent_app_date] => 2009-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9918
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068200.pdf
[firstpage_image] =>[orig_patent_app_number] => 12558797
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/558797 | Methods and Compositions for Inhibiting Atherosclerosis and Vascular Inflammation | Sep 13, 2009 | Abandoned |
Array
(
[id] => 8006193
[patent_doc_number] => 08084497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-27
[patent_title] => 'C-(2-phenyl-cyclohexyl)-methylamine compounds for therapy of fibromyalgia'
[patent_app_type] => utility
[patent_app_number] => 12/558896
[patent_app_country] => US
[patent_app_date] => 2009-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6175
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/084/08084497.pdf
[firstpage_image] =>[orig_patent_app_number] => 12558896
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/558896 | C-(2-phenyl-cyclohexyl)-methylamine compounds for therapy of fibromyalgia | Sep 13, 2009 | Issued |
Array
(
[id] => 6249504
[patent_doc_number] => 20100137443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Ibuprofen for Topical Administration'
[patent_app_type] => utility
[patent_app_number] => 12/557470
[patent_app_country] => US
[patent_app_date] => 2009-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4368
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137443.pdf
[firstpage_image] =>[orig_patent_app_number] => 12557470
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/557470 | Ibuprofen for Topical Administration | Sep 9, 2009 | Abandoned |
Array
(
[id] => 6223045
[patent_doc_number] => 20100056540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'STABLE PHARMACEUTICAL COMPOSITION FOR OPTIMIZED DELIVERY OF AN HIV ATTACHMENT INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 12/553310
[patent_app_country] => US
[patent_app_date] => 2009-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4687
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20100056540.pdf
[firstpage_image] =>[orig_patent_app_number] => 12553310
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/553310 | STABLE PHARMACEUTICAL COMPOSITION FOR OPTIMIZED DELIVERY OF AN HIV ATTACHMENT INHIBITOR | Sep 2, 2009 | Abandoned |